Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancerMyrto Moutafi, David L. Rimm, Charles T. Robbins et al.|Laboratory Investigation|2022Cited by 141
Novel antibody probes for the characterization of endosialin/TEM-1Daniel J. O’Shannessy, Nicholas C. Nicolaides, Earl F. Albone et al.|Oncotarget|2016Cited by 17